The month of March came in like a lion, indeed, but not because of the weather. The month began with a roar as a group of the largest and most influential pharmacy associations and chains came together to form the Patient Access to Pharmacists’ Care Coalition, or PAPCC, in an effort to secure formal federal recognition of pharmacists as healthcare providers.
Mylan on Monday announced the U.S. District Court for the Northern District of West Virginia ruled in favor of upholding the validity of patents protecting Perforomist (formoterol fumarate) Inhalation Solution.
The Drug Store News Group, the leading provider of news, information and clinical education for the retail pharmacy industry, has launched the new microsite, Drugstorenews.com/pain-management, to help bring attention to another tragic side of the prescription drug abuse story — the millions of Americans who live in chronic pain that may be unable to access the medications they need thanks to proposed changes in regulatory policy.
A new analysis from Avalere Health released Monday found that consumers purchasing insurance through exchanges are twice as likely to face utilization management controls on prescription medications compared with people enrolled in employer-sponsored insurance plans.
Actavis earlier this week announced that it has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (methylphenidate transdermal system).
The Consumer Healthcare Products Association on Wednesday released the results of a recent poll of Missouri voters conducted by GS Strategy Group and supported by CHPA that found a clear majority of state residents oppose proposed legislation that would require a prescription for the purchase of pseudoephedrine.
The Electronic Retailing Self-Regulation Program on Tuesday announced it will refer direct response advertising for Dinamo to the Federal Trade Commission and the Food and Drug Administration after the marketer, Natures Flava, failed to respond to an ERSP inquiry.
The American Pharmacists Association’s Academy of Student Pharmacists has named Phillip R. Oppenheimer, who has led University of the Pacific’s Thomas J. Long School of Pharmacy and Health Sciences for almost two decades, as the 2014 Outstanding Dean.
Avella Specialty Pharmacy announced that it has registered with the Food and Drug Administration as an outsourcing facility for sterile compounding as outlined in the recently enacted Drug Quality and Security Act.
The Consumer Healthcare Products Association this year will be focusing on restoring OTC eligibility under flexible spending accounts and helping to finalize OTC monographs, Scott Melville, CHPA president and CEO, told attendees of the 2014 CHPA Annual Executive Conference Tuesday morning.
Last year, $29.3 billion was spent on prescription drugs in Canada, but the annual growth rate was the second-lowest in more than 20 years, according to a new report by the Canadian Institute for Health Information released earlier this month.
A recent audience-research study conducted by Nielsen found that among Cardinal Health's digital advertising network for retail pharmacies, called Pharmacy Health Network, half of viewers surveyed (49%) indicated that they felt encouraged to discuss a product or brand they had seen on Pharmacy Health Network with their pharmacist, and 48% indicated that after seeing ads on Pharmacy Health Network, they felt motivated to discuss those products or brands with their physicians.
The American Pharmacists Association has completed its 2013 Pharmacy-based Influenza and Adult Immunization Survey and found an increase in the administration of numerous vaccines by pharmacists, a growing network of patient referral relationships and steps being taken toward improved documentation practices, the Association has announced.
In a statement, HDMA president and CEO John Gray said the national association representing primary healthcare distributors applauds U.S. Attorney General Eric Holder's weekly address concerning the nation's prescription drug abuse epidemic.
The Cardinal Health Foundation and the Ohio State University College of Pharmacy have announced the introduction of the Medication Safety toolkit, the fifth in a series of interactive toolkits designed to help reduce the abuse of prescription drugs.
Upsher-Smith has received approval from the Food and Drug Administration for Qudexy XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic profile.